| Karen Weimer, MS, LAC | |
|
3715 N Business Dr Ste 104, Fayetteville, AR 72703-5287 | |
| (479) 521-1532 | |
| Not Available |
| Full Name | Karen Weimer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 3715 N Business Dr Ste 104, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073851952 | NPI | - | NPPES |
| 208578795 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | A1801004 (Arkansas) | Secondary |
| 101YP2500X | Counselor - Professional | A1801004 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Weimer, MS, LAC 2400 S 48th St, Springdale, AR 72762-6683 Ph: (479) 750-2020 | Karen Weimer, MS, LAC 3715 N Business Dr Ste 104, Fayetteville, AR 72703-5287 Ph: (479) 521-1532 |
News Archive
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.
A new study reveals that the metadherin gene (MTDH) plays a role in both cancer metastasis and resistance to chemotherapy.
Labor union leaders say the Obama administration's refusal to help with health law provisions they view as unsatisfactory is undermining their support for this year's midterm elections. Meanwhile, the U.S. Chamber of Commerce is looking at ways to fix, rather than repeal, the overhaul.
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.
› Verified 6 days ago
Nancy S Kay, RN, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2894 N Mckee Cir Ste 116, Fayetteville, AR 72703 Phone: 479-225-1111 | |
Jaclyn Mcmillan, BA Counselor Medicare: Not Enrolled in Medicare Practice Location: 2153 E Joyce Blvd, Suite 201, Fayetteville, AR 72703 Phone: 479-575-9471 Fax: 479-587-9392 | |
Alexandra Gackle, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 28 S College Ave Ste 4a, Fayetteville, AR 72701 Phone: 913-669-8795 | |
Ms. Lois Faye Jacoby, LCSW, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Bldg 44, Fayetteville, AR 72703 Phone: 479-444-5078 | |
Robert Lee Walton Iii, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 720-217-7596 | |
Lenore Henderson, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4253 N Crossover Rd, Fayetteville, AR 72703 Phone: 479-443-6496 Fax: 479-443-2519 | |
Talor M Tartaglia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-695-1240 Fax: 479-750-4843 |